| P50 | author | Jan Wehkamp | Q42715392 |
| P2093 | author name string | Eduard F Stange | |
| P2860 | cites work | Inflammatory Bowel Disease | Q22248115 |
| | High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease | Q22250942 |
| | A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease | Q22251291 |
| | Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic | Q24290539 |
| | Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial | Q24685494 |
| | Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease | Q27860821 |
| | Antimicrobial peptides of multicellular organisms | Q28131811 |
| | Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense | Q28145389 |
| | Defensins: antimicrobial peptides of innate immunity | Q28204453 |
| | Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria | Q28204776 |
| | A peptide antibiotic from human skin | Q28242199 |
| | Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract | Q28587612 |
| | Genotypes and phenotypes in Crohn's disease: do they help in clinical management? | Q30478821 |
| | Crohn's disease and the NOD2 gene: a role for paneth cells | Q33187690 |
| | Antibiotic peptides as mediators of innate immunity | Q33987884 |
| | Paneth cell trypsin is the processing enzyme for human defensin-5. | Q34129474 |
| | Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin | Q34186394 |
| | Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells | Q34407161 |
| | Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease | Q34523071 |
| | Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression | Q34716119 |
| | "For whom the bell tolls!" -- innate defense mechanisms and survival strategies of the intestinal epithelium against lumenal pathogens | Q35041259 |
| | Crohn's disease: a defensin deficiency syndrome? | Q35168862 |
| | Antimicrobial peptides in innate immunity of the human intestine | Q35541235 |
| | Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease | Q35993236 |
| | The Paneth cell and the innate immune response | Q36036656 |
| | Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells | Q37617129 |
| | NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. | Q40017434 |
| | Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer | Q40538834 |
| | Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. | Q40692879 |
| | NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression | Q41917631 |
| | Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. | Q42161372 |
| | Mucosal flora in inflammatory bowel disease | Q43503928 |
| | Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. | Q54762013 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Crohn's disease | Q1472 |
| P304 | page(s) | 321-331 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | A new look at Crohn's disease: breakdown of the mucosal antibacterial defense | |
| P478 | volume | 1072 | |